Filters

CHRNA7 Antibody, Cy5 Conjugated

CHRNA7 Antibody, Cy5 Conjugated size: 0.1ml 350

Price 350
Size 0.1ml
Long name Cy5 Conjugated, CHRNA7 Polyclonal Antibody
CategoryConjugated Primary Antibodies
Conjugation5, Cy5
Host OrganismRabbit (Oryctolagus cuniculus)
Target AntigenCHRNA7
SpecificityThis is a highly specific antibody against CHRNA7
ModificationUnmodified
Modification siteNone
ClonalityPolyclonal
ClonePolyclonal antibody
Concentration1ug per 1ul
Immunogen_range491-502/502
SourceKLH conjugated synthetic peptide derived from human CHRNA7
Gene ID number1139
Swiss ProtP36544
Tested applicationsIF(IHC-P)
Recommended dilutionsIF(IHC-P)(1:50-200)
Crossreactivity Mouse, Rat, Human
Crossreactive species details not every possible cross-reactivity is known, Due to limited amount of testing and knowledge
Antigen background The channel is blocked by alpha-bungarotoxin, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane, After binding acetylcholine
Purification methodThis antibody was purified via Protein A
Storage conditions 50% glycerol and 0, Store refrigerated at 2 to 8 degrees Celcius for up to 1 year, 09% sodium azide, Keep the antibody in an aqueous buffered solution containing 1% BSA
Excitation Emission625, 650nm/670nm
Properties Cy5 antibodies are excited by the 650-nanometer wave of an argon laser and detected at a 670-nanometer captor, C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Conjugated Antibodies they should be stored frozen at - 24°
Gene targetCHRNA7 Conjugated
Short name Conjugated, CHRNA7 Antibody
Technique antibodies against human proteins, antibodies for, antibody Conjugates, Antibody
LabelCy5
Alternative name a 7 (neuronal) (Antibody to), cyanine 5 coupled, nicotinic, cholinergic receptor
Alternative techniqueantibodies
Alternative to gene target CHRNA7 and IDBG-5070 and ENSG00000175344 and 1139, CHRNA7 and IDBG-630821 and ENSBTAG00000015775 and 282178, CHRNA7-2 and NACHRA7, Cell surfaces, Chrna7 and IDBG-190675 and ENSMUSG00000030525 and 11441, alpha 7 (neuronal), nicotinic, protein homodimerization activity, this GO :0000187 and activation of MAPK activity and biological process this GO :0001540 and beta-amyloid binding and molecular function this GO :0001666 and response to hypoxia and biological process this GO :0004889 and acetylcholine-activated cation-selective channel activity and molecular function this GO :0005230 and extracellular ligand-gated ion channel activity and molecular function this GO :0005886 and plasma membrane and cellular component this GO :0005892 and acetylcholine-gated channel complex and cellular component this GO :0006810 and transport and biological process this GO :0006811 and ion transport and biological process this GO :0006816 and calcium ion transport and biological process this GO :0006874 and cellular calcium ion homeostasis and biological process this GO :0007165 and signal transduction and biological process this GO :0007268 and synaptic transmission and biological process this GO :0007613 and memory and biological process this GO :0008284 and positive regulation of cell proliferation and biological process this GO :0015464 and acetylcholine receptor activity and molecular function this GO :0015643 and toxic substance binding and molecular function this GO :0016020 and membrane and cellular component this GO :0016021 and integral component of membrane and cellular component this GO :0017081 and chloride channel regulator activity and molecular function this GO :0022848 and acetylcholine-gated cation channel activity and molecular function this GO :0030054 and cell junction and cellular component this GO :0032720 and negative regulation of tumor necrosis factor production and biological process this GO :0034220 and ion transmembrane transport and biological process this GO :0035094 and response to nicotine and biological process this GO :0042166 and acetylcholine binding and molecular function this GO :0042803 and protein homodimerization activity and molecular function this GO :0045211 and postsynaptic membrane and cellular component this GO :0045766 and positive regulation of angiogenesis and biological process this GO :0050890 and cognition and biological process, this GO :0001540: beta-amyloid binding, this GO :0001540: beta-amyloid binding and also this GO :0004889: acetylcholine-activated cation-selective channel activity and also this GO :0005230: extracellular ligand-gated ion channel activity and also this GO :0015464: acetylcholine receptor activity and also this GO :0015643: toxic substance binding and also this GO :0017081: chloride channel regulator activity and also this GO :0022848: acetylcholine-gated cation channel activity and also this GO :0042166: acetylcholine binding and also this GO :0042803: protein homodimerization activity, this GO :0004889: acetylcholine-activated cation-selective channel activity, this GO :0005230: extracellular ligand-gated ion channel activity, this GO :0015464: acetylcholine receptor activity, this GO :0015643: toxic substance binding, this GO :0017081: chloride channel regulator activity, this GO :0022848: acetylcholine-gated cation channel activity, this GO :0042166: acetylcholine binding, this GO :0042803: protein homodimerization activity, 89832, cholinergic receptor
Identity 1960
Gene CHRNA7
Long gene name cholinergic receptor nicotinic alpha 7 subunit
Synonyms gene name alpha 7 (neuronal) cholinergic receptor, alpha polypeptide 7 cholinergic receptor, cholinergic receptor, nicotinic, nicotinic, nicotinic alpha 7
Synonyms name acetylcholine receptor, alpha 7 (neuronal) , nicotinic
Locus 15q13, 3
Discovery year 1993-05-25
GenBank acession Z23141
Entrez gene record 1139
Pubmed identfication 8188270
Classification Cholinergic receptors nicotinic subunits
Havana BLAST/BLAT OTTHUMG00000129285

Subscribe to our Newsletter